Advanced

Access to highly active antiretroviral therapy (HAART) in the WHO European Region 2003-2005

Bollerup, Annemarie R; Donoghoe, Martin C; Lazarus, Jeffrey LU ; Nielsen, Stine and Matic, Srdan (2008) In Scandinavian Journal of Public Health 36(2). p.183-189
Abstract
Aims: To assess changes in access to highly active antiretroviral therapy (HAART) between the end of 2002 and the end of 2005, and to review the capacity for further HAART scale-up in the then 52 Member States of the WHO European Region. Methods: Analysis of data from four surveys evaluating access to HAART, supplemented by regional estimates of the number of people receiving HAART. Changes in access to HAART are evaluated in terms of changes in the number of people receiving HAART over time and changes in country-level HAART coverage. Results: During 2003-2005, the total number of individuals receiving HAART increased by an estimated 101,000, from 242,000 to 343,000 (a 42% increase); 85,000 were in the west region (a 36% increase) and... (More)
Aims: To assess changes in access to highly active antiretroviral therapy (HAART) between the end of 2002 and the end of 2005, and to review the capacity for further HAART scale-up in the then 52 Member States of the WHO European Region. Methods: Analysis of data from four surveys evaluating access to HAART, supplemented by regional estimates of the number of people receiving HAART. Changes in access to HAART are evaluated in terms of changes in the number of people receiving HAART over time and changes in country-level HAART coverage. Results: During 2003-2005, the total number of individuals receiving HAART increased by an estimated 101,000, from 242,000 to 343,000 (a 42% increase); 85,000 were in the west region (a 36% increase) and 16,000 in the centre and east regions (a 229% increase). The number of countries providing "high" coverage with HAART (>75% of those in need receiving it) increased from 29 to 38, and the number of countries providing no HAART declined from eight to four. Conclusions: Despite high and increasing coverage in many European countries, access to HAART remained inequitable in terms of geographical location. By the end of 2005, all countries in the west provided "high" HAART coverage as compared with half of countries in the centre and east. Six east countries still provided poor or no HAART coverage. Countries must address how to further equitably increase the number of people receiving HAART. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
HIV/AIDS, antiretroviral therapy, access, Europe
in
Scandinavian Journal of Public Health
volume
36
issue
2
pages
183 - 189
publisher
Taylor & Francis
external identifiers
  • wos:000255067200010
  • scopus:40549109293
ISSN
1651-1905
DOI
10.1177/1403494807085191
language
English
LU publication?
yes
id
a0fcca3e-f8bf-4eb2-bfc2-460429215df5 (old id 1205632)
date added to LUP
2008-09-19 11:34:49
date last changed
2017-01-01 05:54:53
@article{a0fcca3e-f8bf-4eb2-bfc2-460429215df5,
  abstract     = {Aims: To assess changes in access to highly active antiretroviral therapy (HAART) between the end of 2002 and the end of 2005, and to review the capacity for further HAART scale-up in the then 52 Member States of the WHO European Region. Methods: Analysis of data from four surveys evaluating access to HAART, supplemented by regional estimates of the number of people receiving HAART. Changes in access to HAART are evaluated in terms of changes in the number of people receiving HAART over time and changes in country-level HAART coverage. Results: During 2003-2005, the total number of individuals receiving HAART increased by an estimated 101,000, from 242,000 to 343,000 (a 42% increase); 85,000 were in the west region (a 36% increase) and 16,000 in the centre and east regions (a 229% increase). The number of countries providing "high" coverage with HAART (>75% of those in need receiving it) increased from 29 to 38, and the number of countries providing no HAART declined from eight to four. Conclusions: Despite high and increasing coverage in many European countries, access to HAART remained inequitable in terms of geographical location. By the end of 2005, all countries in the west provided "high" HAART coverage as compared with half of countries in the centre and east. Six east countries still provided poor or no HAART coverage. Countries must address how to further equitably increase the number of people receiving HAART.},
  author       = {Bollerup, Annemarie R and Donoghoe, Martin C and Lazarus, Jeffrey and Nielsen, Stine and Matic, Srdan},
  issn         = {1651-1905},
  keyword      = {HIV/AIDS,antiretroviral therapy,access,Europe},
  language     = {eng},
  number       = {2},
  pages        = {183--189},
  publisher    = {Taylor & Francis},
  series       = {Scandinavian Journal of Public Health},
  title        = {Access to highly active antiretroviral therapy (HAART) in the WHO European Region 2003-2005},
  url          = {http://dx.doi.org/10.1177/1403494807085191},
  volume       = {36},
  year         = {2008},
}